163 related articles for article (PubMed ID: 3312117)
41. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine.
Pacini F; Cetani F; Miccoli P; Mancusi F; Ceccarelli C; Lippi F; Martino E; Pinchera A
World J Surg; 1994; 18(4):600-4. PubMed ID: 7725751
[TBL] [Abstract][Full Text] [Related]
42. Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
Schlumberger M; Catargi B; Borget I; Deandreis D; Zerdoud S; Bridji B; Bardet S; Leenhardt L; Bastie D; Schvartz C; Vera P; Morel O; Benisvy D; Bournaud C; Bonichon F; Dejax C; Toubert ME; Leboulleux S; Ricard M; Benhamou E;
N Engl J Med; 2012 May; 366(18):1663-73. PubMed ID: 22551127
[TBL] [Abstract][Full Text] [Related]
43. Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma.
Siddiqui AR; Edmondson J; Wellman HN; Hamaker RC; Lingeman RE; Park HM; Johnston CC
Clin Nucl Med; 1981 Apr; 6(4):158-61. PubMed ID: 7214770
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
45. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
[TBL] [Abstract][Full Text] [Related]
46. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
Lin JD; Kao PF; Chao TC
Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
[TBL] [Abstract][Full Text] [Related]
47. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
Bal CS; Kumar A; Pant GS
J Clin Endocrinol Metab; 2004 Apr; 89(4):1666-73. PubMed ID: 15070929
[TBL] [Abstract][Full Text] [Related]
48. Pulmonary metastases from differentiated thyroid carcinoma demonstrable only by nuclear imaging.
Bonte FJ; McConnell RW
Radiology; 1973 Jun; 107(3):585-90. PubMed ID: 4702537
[No Abstract] [Full Text] [Related]
49. Radionuclides and therapy of thyroid cancer.
O'Doherty MJ; Nunan TO; Croft DN
Nucl Med Commun; 1993 Sep; 14(9):736-55. PubMed ID: 8233239
[TBL] [Abstract][Full Text] [Related]
50. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
[TBL] [Abstract][Full Text] [Related]
51. Failure of low doses of 131I to ablate residual thyroid tissue following surgery for thyroid cancer.
Kuni CC; Klingensmith WC
Radiology; 1980 Dec; 137(3):773-4. PubMed ID: 7444061
[TBL] [Abstract][Full Text] [Related]
52. Differentiated thyroid carcinoma in children and adolescents. Clinical characteristics, treatment and outcome of 15 patients.
Arici C; Erdogan O; Altunbas H; Boz A; Melikoglu M; Karayalcin B; Karpuzoglu T
Horm Res; 2002; 57(5-6):153-6. PubMed ID: 12053086
[TBL] [Abstract][Full Text] [Related]
53. Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis.
Mello AM; Isaacs R; Petersen J; Kronenberger S; McDougall IR
Clin Nucl Med; 1994 Sep; 19(9):776-81. PubMed ID: 7982310
[TBL] [Abstract][Full Text] [Related]
54. Thyroglobulin-guided (131)I ablation in low-risk differentiated thyroid carcinoma: is the yardstick accurate enough?
Giovanella L
Head Neck; 2011 Sep; 33(9):1379-80; author reply 1380-1. PubMed ID: 21739512
[No Abstract] [Full Text] [Related]
55. The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma.
Pelikan DM; Lion HL; Hermans J; Goslings BM
Clin Endocrinol (Oxf); 1997 Dec; 47(6):713-20. PubMed ID: 9497879
[TBL] [Abstract][Full Text] [Related]
56. Long-term survival of thyroid carcinoma with metastatic disease treated with radioiodine.
Lackey RW
Int J Nucl Med Biol; 1978; 5(6):255-9. PubMed ID: 738840
[No Abstract] [Full Text] [Related]
57. Assessment of the efficacy of iodine-131 for thyroid ablation.
Comtois R; Thériault C; Del Vecchio P
J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
[TBL] [Abstract][Full Text] [Related]
58. Proceedings: Management of cancer of the thyroid: a summary.
Strong EW
Proc Natl Cancer Conf; 1972; 7():179-85. PubMed ID: 4587645
[No Abstract] [Full Text] [Related]
59. [Clinical study on pulmonary metastases of differentiated thyroid carcinoma--with special reference to the extent of thyroid resection and RI therapy].
Ozaki O; Ito K; Manabe Y; Nishikawa Y; Mimura T
Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1596-9. PubMed ID: 4088188
[TBL] [Abstract][Full Text] [Related]
60. [Current state of the treatment of thyroid cancer].
Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA
Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
